Trial Profile
Safety and efficacy of desmopressin for the treatment of nocturia in patients with Parkinson's disease and multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- 15 Dec 2015 New trial record